|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/198 | (2006.01) |
| A61P 29/00 | (2006.01) |
| (11) | Number of the document | 3934637 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20712029.6 |
| Date of filing the European patent application | 2020-03-02 | |
| (97) | Date of publication of the European application | 2022-01-12 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-31 |
| (46) | Date of publication of the claims translation | 2024-08-26 |
| (86) | Number | PCT/IB2020/051767 |
| Date | 2020-03-02 |
| (87) | Number | WO 2020/178721 |
| Date | 2020-09-10 |
| (30) | Number | Date | Country code |
| 201962812987 P | 2019-03-02 | US | |
| 201962842296 P | 2019-05-02 | US | |
| 201962888894 P | 2019-08-19 | US | |
| 201962895144 P | 2019-09-03 | US |
| (72) |
FACTOR, Mallory , GB
FIELDS, Taylor , GB
|
| (73) |
IntraBio Ltd ,
Summit House
170 Finchley Road, London NW3 6BP,
GB
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | (N-)acetil-L-leucinas, skirtas panaudoti trauminio smegenų pažeidimo gydymui |
| (N-)ACETYL-L-LEUCINE FOR USE IN TREATING TRAUMATIC BRAIN INJURY |
| Payment date | Validity (years) | Amount | |
| 2026-01-21 | 7 | 162.00 EUR |
| 2027-03-02 |